Morgan Stanley »

Beam Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2023-09-30 $13M 522k 24.05
2023-06-30 $27M 835k 31.93
2022-12-31 $25M 649k 39.11
2022-06-30 $23M 604k 38.74
2022-03-31 $32M 552k 57.30
2021-06-30 $39M 302k 130.43
2020-12-31 $4.6M 56k 81.63
2020-09-30 $901k 37k 24.61
2020-06-30 $578k 21k 27.92
2020-03-31 $30k 1.7k 17.89